Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules.
Activation of inflammatory cells is central to the pathogenesis of autoimmune demyelinating diseases of the peripheral nervous system. The novel chimeric compound quinpramine--generated from imipramine and quinacrine--redistributes cholesterol rich membrane domains to intracellular compartments. We...
Guardado en:
Autores principales: | Gerd Meyer zu Hörste, Anne K Mausberg, Johanna I Müller, Helmar C Lehmann, Stefan Löber, Peter Gmeiner, Hans-Peter Hartung, Olaf Stüve, Carsten Korth, Bernd C Kieseier |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c25d308f220f4236916dec59160e4b9f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathies.
por: Gerd Meyer zu Hörste, et al.
Publicado: (2014) -
Traditional Chinese medicine Yisui Tongjing relieved neural severity in experimental autoimmune neuritis rat model
por: Zhang E, et al.
Publicado: (2016) -
Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines
por: Channakeshava Sokke Umeshappa, et al.
Publicado: (2019) -
Associations of GWAS-Supported Non-MHC Genes with Autoimmune Thyroiditis in Patients with Type 1 Diabetes
por: Liang J, et al.
Publicado: (2021) -
Tissue mRNA expression in rat of newly described matrix metalloproteinases
por: BERNAL,FABIÁN, et al.
Publicado: (2005)